Raymond James & Associates’s Elicio Therapeutics ELTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,000	Closed	-$34.8K	–	3801
2023 Q1	$34.8K	Hold	6,000	–	–	﹤0.01%	3715
2022 Q4	$48.7K	Hold	6,000	–	–	﹤0.01%	3662
2022 Q3	$55K	Hold	6,000	–	–	﹤0.01%	3652
2022 Q2	$68K	Buy	+6,000	New	+$68K	﹤0.01%	3702